Diversity of Bacterial Clones and Plasmids of NDM-1 Producing Escherichia coli Clinical Isolates in Central Greece.
Katerina TsilipounidakiZoi FlorouAnargyros SkoulakisGeorge C FthenakisVivi MiriagouEfthymia PetinakiPublished in: Microorganisms (2023)
The objective of the present study was to genetically characterize ten NDM-1 producing Escherichia coli isolates, recovered from patients in a hospital in Central Greece during the period 2017 to 2021.The isolates were studied by whole genome sequencing to obtain multi-locus sequencing typing (MLST), identification of bla NDM1 -environment, resistome and plasmid content. MLST analysis showed the presence of eight sequence types: ST46* (two isolates), ST46, ST744, ST998, ST410, ST224, ST4380, ST683 and ST12 (one isolate each). Apart of the presence of bla NDM-1 , the isolates carried a combination of various to β -lactams encoding resistance genes: bla TEM-1B , bla CTX-15 , bla OXA-1 , bla VIM-1 , bla SHV-5 , bla OXA-16 , bla OXA-10 and bla VEB-1 . Additionally, plurality of resistance genes to aminoglycosides, macrolides, rifamycin, phenicols, sulfonamides and tetracycline was detected. The presence of multiple replicons was observed, with predominance of IncFII and IncFIB. Analysis of bla NDM-1 genetic environment of the isolates showed that seven had 100% identity with the pS-3002cz plasmid (Accession Number KJ 958927), two with the pB-3002cz plasmid (Accession Number KJ958926) and one with the pEc19397-131 plasmid (Accession Number MG878866). Τhis latter plasmid was derived by the fusion of two, previously identified, plasmids, pAMPD2 and pLK75 (Accession Numbers CP078058 and KJ440076, respectively). The diversity of clones and plasmids of NDM-1 producing E. coli isolated from patients in Greece indicates a continuous horizontal gene transfer.
Keyphrases
- klebsiella pneumoniae
- escherichia coli
- multidrug resistant
- biofilm formation
- genome wide
- genetic diversity
- newly diagnosed
- ejection fraction
- prognostic factors
- dna methylation
- healthcare
- emergency department
- gene expression
- drug resistant
- transcription factor
- heavy metals
- risk assessment
- copy number
- single cell
- mass spectrometry
- cystic fibrosis
- patient reported outcomes
- tandem mass spectrometry
- genome wide identification
- genome wide analysis